- Home
- KNSA vs DNN Comparison
KNSA vs DNN Comparison
Compare KNSA & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | DNN |
|---|---|---|
| Founded | 2015 | 1954 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3B |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | KNSA | DNN |
|---|---|---|
| Price | $42.83 | $4.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $56.00 | $6.50 |
| AVG Volume (30 Days) | 559.8K | ★ 32.2M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.60 | $403.36 |
| Revenue Next Year | $17.77 | N/A |
| P/E Ratio | $56.47 | ★ N/A |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $20.24 | $1.39 |
| 52 Week High | $50.03 | $4.43 |
Technical Indicators
Market Signals| Indicator | KNSA | DNN |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 61.23 |
| Support Level | $41.98 | $3.31 |
| Resistance Level | $42.91 | $4.42 |
| Average True Range (ATR) | 1.93 | 0.21 |
| MACD | -0.65 | 0.05 |
| Stochastic Oscillator | 15.69 | 99.25 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.